The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

compared to about 16% of those taking Wegovy, the AP reported, citing the study. Researchers explained in the study that ...

Fact checked by Jennifer Klump People who use Wegovy for weight management may be at higher risk for hair loss, according to ...

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

Packets of Wegovy ... a hair-loss condition compared to those prescribed Contrave. That risk was twice as high for women as for men. Read More: The Health Risks and Benefits of Weight-Loss Drugs ...

Wegovy comes in higher doses than Ozempic and ... The 2-milligram dose was found to induce more body weight loss than the 1-milligram dose. After 40 weeks, those taking 1 milligram of semaglutide ...

The U.S. Food and Drug Administration has accepted Novo Nordisk’s application for an oral version of its blockbuster weight loss drug Wegovy. The Danish drugmaker – which has its U.S ...

Semaglutide is the compound in the drugs Ozempic, which treats diabetes, and Wegovy ... twice as high for women as for men. Read More: The Health Risks and Benefits of Weight-Loss Drugs While ...